MARIA Modica

Dr. MARIA Modica

Dipartimento di Scienze del Farmaco
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
SISebastiano Intagliata
Sebastiano Intagliata
MARIA ModicaMARIA Modica
MARIA Modica
LSLudovica Maria Santagati
Ludovica Maria Santagati
Lucia MontenegroLucia Montenegro
Lucia Montenegro
In recent years, a great deal of attention has been paid to natural compounds due to their many biological effects. Polyphenols are a class of plant derivatives that have been widely investigated for preventing and treating many oxidative stress-related pathological conditions, such as neurodegenerative and cardiovascular diseases, cancer, diabetes mellitus and inflammation. Among these polyphenols, resveratrol (RSV) has attracted considerable interest owing to its high antioxidant and free radical scavenging activities. However, the poor water solubility and rapid metabolism of RSV lead to low bioavailability, thus limiting its clinical efficacy. After discussing the main biochemical mechanisms involved in RSV biological activities, this review will focus on the strategies attempted to improve RSV effectiveness, both for systemic and for topical administration. In particular, technological approaches involving RSV incorporation into different delivery systems such as liposomes, polymeric and lipid nanoparticles, microemulsions and cyclodextrins will be illustrated, highlighting their potential clinical applications. In addition, chemical modifications of this antioxidant aimed at improving its physicochemical properties will be described along with the results of in vitro and in vivo studies.

4 July 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMaria A. Siracusa
Maria A. Siracusa
LSLoredana Salerno
Loredana Salerno
MARIA ModicaMARIA Modica
MARIA Modica
Valeria PittalàValeria Pittalà
Valeria Pittalà
Giuseppe RomeoGiuseppe Romeo
Giuseppe Romeo
TMTiziana Mennini
Tiziana Mennini

2 June 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
AFAntonino N. Fallica
Antonino N. Fallica
Valeria PittalàValeria Pittalà
Valeria Pittalà
MARIA ModicaMARIA Modica
MARIA Modica
Loredana SalernoLoredana Salerno
Loredana Salerno
Giuseppe RomeoGiuseppe Romeo
Giuseppe Romeo
SISebastiano Intagliata
Sebastiano Intagliata
Since their discovery as distinct receptor proteins, the specific physiopathological role of sigma receptors (σRs) has been deeply investigated. It has been reported that these proteins, classified into two subtypes indicated as σ1 and σ2, might play a pivotal role in cancer growth, cell proliferation, and tumor aggressiveness. As a result, the development of selective σR ligands with potential antitumor properties attracted significant attention as an emerging theme in cancer research. This perspective deals with the recent advances of σR ligands as novel cytotoxic agents, covering articles published between 2010 and 2020. An up-to-date description of the medicinal chemistry of selective σ1R and σ2R ligands with antiproliferative and cytotoxic activities has been provided, including major pharmacophore models and comprehensive structure–activity relationships for each main class of σR ligands.

1 September 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Loredana SalernoLoredana Salerno
Loredana Salerno
Valeria PittalàValeria Pittalà
Valeria Pittalà
Giuseppe RomeoGiuseppe Romeo
Giuseppe Romeo
MARIA ModicaMARIA Modica
MARIA Modica
MSMaria A. Siracusa
Maria A. Siracusa
VSValeria Sorrenti
Valeria Sorrenti


1 February 1997 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MARIA ModicaMARIA Modica
MARIA Modica
MSMaria Santagati
Maria Santagati
FRFilippo Russo
Filippo Russo
LPLuca Parotti
Luca Parotti
LGLuca De Gioia
Luca De Gioia
TMTiziana Mennini
Tiziana Mennini